What You Should Know:
- The Medical University of South Carolina (MUSC) Hollings Cancer Center and Flatiron Health, a leading oncology-focused healthtech company, today announced a collaboration to bring Flatiron Assist™ to MUSC's oncology care clinicians.
- The strategic collaboration equips clinicians at MUSC Hollings Cancer Center with Flatiron Assist, a unique clinical decision support platform designed specifically for oncology. Flatiron Assist prioritizes the latest
Read More
Oncology Technology Solutions, Services Impacting Patients and Providers
Thyme Care Launches VBC Platform w/ 400+ Oncologists
What You Should Know:
- Thyme Care, a leader in value-based cancer care, has launched Thyme Care Oncology Partners (TCOP), a dedicated platform designed to support oncology practices in the transition to value-based care models.
- Through partnerships with payers and providers, Thyme Care's TCOP platform fosters collaboration and prioritizes patient-centric care while reducing costs. This innovative approach positions Thyme Care as a leader in shaping the future of value-based cancer
Read More
Oracle-Backed Cancer Startup Project Ronin Shutters
What You Should Know:
- Project Ronin, a software startup focused on applying AI to improve cancer care, announced its closure, Bloomberg first reports.
- The company, co-founded by Oracle co-founder and chairman Larry Ellison, cited financial difficulties as the primary reason for the shutdown.
Project Ronin Background
Founded in 2018, Ronin aimed to develop solutions that could rapidly analyze and interpret data within electronic health records systems used by hospitals.
Read More
Belong.Life Launches Conversational AI Cancer Mentor
What You Should Know:
Belong.Life, a leading global provider of AI-powered patient education and support solutions, has unveiled the BelongAI Dave - Cancer Mentor app to bring the most advanced and comprehensive cancer support technology to patients and caregivers around the world.The new solution marks a significant step forward in personalized cancer support, by providing patients with a proactive and comprehensive conversational-AI solution for managing their journey
Read More
6 Ways AI is Impacting Cancer Diagnosis, Treatment and Patient Outcomes in 2024
Artificial intelligence (AI) technology is set to transform the field of diagnostics, similar to how X-rays and genetic tests revolutionized healthcare in the past. Reshaping routine diagnostic procedures and treatment decisions and propelling pharmaceutical and research domains into new realms, AI offers significant benefits to clinicians, healthcare systems, researchers, and, most importantly, patients. This is particularly evident in cancer diagnosis and treatment across six key areas:
1.
Read More
ConcertAI Acquires CancerLinQ to Expand Real-World Data and AI Solutions for Cancer Care
What You Should Know:
- ConcertAI, a developer of AI-powered healthcare solutions, announced today the acquisition of CancerLinQ, a subsidiary of the American Society of Clinical Oncology (ASCO).
- This strategic move will significantly enhance and expand CancerLinQ's capabilities, unlocking the potential of real-world data and next-generation AI to revolutionize cancer care and accelerate clinical research.
CancerLinQ Background
CancerLinQ represents one of the largest oncology
Read More
Syapse and FDA OCE Collaborate to Advance Real-World Evidence in Oncology
What You Should Know:
- Syapse®, a leading real-world evidence (RWE) company dedicated to extinguishing the fear and burden of serious diseases, and the FDA Oncology Center of Excellence (OCE) today announced the renewal of their four-year collaboration agreement.
- This expanded strategic partnership aims to collaboratively develop and implement research projects that advance the use of real-world data (RWD) and explore the potential of RWE to inform regulatory decisions in
Read More
Absci and AstraZeneca Sign $247M Partnership for AI-Powered Drug Discovery to Fight Cancer
What You Should Know:
- Absci Corporation (ABSI), a pioneer in using generative AI to discover antibodies, and AstraZeneca, a global biopharmaceutical leader, announced a collaboration today to develop an AI-designed antibody for cancer.
- This partnership combines Absci's cutting-edge Integrated Drug Creation™ platform with AstraZeneca's oncology expertise, aiming to accelerate the discovery of a potential new cancer treatment.
Absci's AI Engine Takes the Lead
Absci will leverage
Read More
Guardant Health, Flatiron Health Integrate Genomic Profiling Tests into OncoEMR® Platform
Georgiamune and Verily Partner to Advance Novel Cancer Treatment
What You Should Know:
- Georgiamune, a privately held, clinical stage biotechnology company, and Verily, an Alphabet precision health technology company forms a strategic partnership to advance novel therapeutics for patients with cancer.
- Through this partnership, Verily and Georgimune will focus on identifying the patient population that could potentially benefit the most from Georgiamune’s GIM-122, a first-in-class dual-functioning antibody that has the potential to help patients with
Read More
